Brain tumor-related epilepsy

Current Neuropharmacology

Volumn 10, Issue 2, 2012, Pages 124-133

  Maschio, Marta ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Antiepileptics; Brain tumor related epilepsy; Chemotherapy; Epilepsy; Pharmacological interactions; Quality of life; Side effects

Indexed keywords

ANASTROZOLE; BLEOMYCIN; CAPECITABINE; CARBAMAZEPINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; ETIRACETAM; FELBAMATE; FLUOROURACIL; GABAPENTIN; GEMCITABINE; HARKOSERIDE; LAMOTRIGINE; OXALIPLATIN; OXCARBAZEPINE; PEMETREXED; PHENOBARBITAL; PREGABALIN; PRIMIDONE; RITUXIMAB; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; VORINOSTAT; ZONISAMIDE;

ACUTE BRAIN DISEASE; AGGRESSION; AGITATION; ARTICLE; ATAXIA; BRAIN TUMOR; COGNITION; DEPRESSION; DIPLOPIA; DISABILITY; DISEASE CLASSIFICATION; DISEASE DURATION; DIZZINESS; EPILEPSY; EPILEPTOGENESIS; HEADACHE; HUMAN; HYPONATREMIA; INCIDENCE; LEUKOPENIA; NAUSEA; PSYCHOSIS; QUALITY OF LIFE; RISK FACTOR; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA; TREATMENT PLANNING;

EID: 84861745100     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015912800604470     Document Type: Article

References (97)

1. Hildebrand, J. Management of epileptic seizures. Curr. Opin. Oncol., 2004, 16, 314-317.
2. Duffau, H. New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity--a review. J. Neurooncol., 2006, 79, 77-115.
3. Kleihues, P.C., Burger, P.C., Scheithauer, B.W. World Health Organization international histological classification of tumors. Histological typing of 41 tumor of central nervous system. Geneve: Springer, 2000.
4. Ostrom, Q.T., Barnholtz-Sloan, J.S. Current state of our knowledge on brain tumor epidemiology. Curr. Neurol. Neurosci. Rep., 2011, 11, 329-335.
5. Werner, M.H., Phuphanich, S., Lyman, G.H. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer, 1995, 76,1634-1642.
6. Nayak, L., Lee, E.Q., Wen, P.Y. Epidemiology of Brain Metastases. Curr. Oncol. Rep., 2011 Oct 20 [Epub ahead of print].
7. Rossetti, A.O., Stupp, R. Epilepsy in brain tumor patients. Curr. Opin. Neurol., 2010, 23, 603-609.
8. DeAngelis, L.M. Brain tumors. N. Engl. J. Med., 2001, 344, 114-123.
9. Brandes, A.A., Monfardini, S. The treatment of elderly patients with highgrade gliomas. Semin. Oncol., 2003, 30(6 Suppl 19), 58-62.
10. Olson, J.D., Riedel, E., De Angelis, L.M. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology, 2000, 54, 1442-1448.
11. Luyken, C., Blümcke, I., Fimmers, R., Urbach, H., Elger, C.E., Wiestler, O.D., Schramm, J. The spectrum of long-term epilepsyassociated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia, 2003, 44, 822-830.
12. Singh, G., Rees, J.H., Sander, J.W. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J. Neurol. Neurosurg. Psychiatry, 2007, 78,342-349.
13. Raizer, J. Issues in developing drugs for primary brain tumors: barriers and toxicities. Toxicol. Pathol., 2011, 39, 152-157.
14. Kargiotis, O., Markoula, S., Kyritsis, A.P. Epilepsy in the cancer patient. Cancer Chemother. Pharmacol., 2011, 67,489-501.
15. Klein, M., Engelberts, N.H., van der Ploeg, H.M., Kasteleijn-Nolst Trenité, D.G., Aaronson, N.K., Taphoorn, M.J., Baaijen, H., Vandertop, W.P., Muller, M., Postma, T.J., Heimans, J.J. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann. Neurol., 2003, 54, 514-520.
16. Glantz, M.J., Cole, B.F., Forsyth, P.A., Recht, L.D., Wen, P.Y., Chamberlain, M.C., Grossman, S.A., Cairncross, J.G. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology, 2000, 54, 1886-1893.
17. Hildebrand, J., Lecaille, C., Perennes, J., Delattre, J.Y. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology, 2005, 65, 212-215.
18. Wen, P.Y., Marks, P.W. Medical management of patients with brain tumors. Curr. Opin. Oncol., 2002, 14, 299-307.
19. Telfeian, A.E., Philips, M.F., Crino, P.B., Judy, K.D. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme. J. Exp. Clin. Cancer Res., 2001, 20, 5-10.
20. Vecht, C.J., Wilms, E.B. Seizures in low-and high-grade gliomas: current management and future outlook. Expert Rev. Anticancer Ther., 2010, 10, 663-669.
21. Bromfield, E.B. B Epilepsy in patients with brain tumors and other cancers. Rev. Neurol. Dis., 2004, 1 Suppl 1, S27-33.
22. Forsgren, I., Beghi, E., Ekman, M. Cost of epilepsy in Europe. Eur. J. Neurol., 2005, 12 Suppl 1, 54-58.
23. Patchell, R.A. The management of brain metastases. Cancer Treat Rev., 2003, 29, 533-540.
24. Kaal, E.C., Niël, C.G., Vecht, C.J. Therapeutic management of brain metastasis. Lancet Neurol., 2005, 4, 289-298.
25. Lim, L.C., Rosenthal, M.A., Maartens, N., Ryan, G. Management of brain metastases. Intern. Med. J., 2004, 34, 270-278.
26. Davey, P. Brain metastases: treatment options to improve outcomes. CNS Drugs, 2002, 16, 325-338.
27. Soffietti, R., Cornu, P., Delattre, J.Y., Grant, R., Graus, F., Grisold, W., Heimans, J., Hildebrand, J., Hoskin, P., Kalljo, M., Krauseneck, P., Marosi, C., Siegal, T., Vecht, C. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur. J. Neurol., 2006, 13, 674-681.
28. Gavrilovic, I.T., Posner, J.B. Brain metastases: epidemiology and pathophysiology. J. Neurooncol., 2005, 75, 5-14.
29. van den Bent, M.J. The role of chemotherapy in brain metastases. Eur. J. Cancer, 2003, 39, 2114-2120.
30. Ewend, M.G., Elbabaa, S., Carey, L.A. Current treatment paradigms for the management of patients with brain metastases. Neurosurgery, 2005, 57(5 Suppl), S66-77, discussion S1-4.
31. Schaller, B., and Ruegg, S.J. Brain tumor and seizures: pathophysiology and its implications for treatment revised. Epilepsia, 2003, 44, 1223-1232.
32. Whittle, I.R., Beaumont, A. Seizures in patients with supratentorial oligodendroglial tumors: clinicopathological features and management considerations. Acta Neurochir., 1995, 135, 19-24.
33. Berntsson, S.G., Malmer, B., Bondy, M.L., Qu, M., Smits, A. Tumor-associated epilepsy and glioma: are there common genetic pathways? Acta Oncol., 2009, 48, 955-963.
34. Vlodavsky, E., Soustiel, J.F. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival. J. Neurooncol., 2007, 81,1-7.
35. Sontheimer, H. A role for glutamate in growth and invasion of primary brain tumors. J. Neurochem., 2008, 105, 287-295.
36. Jaeckle, K.A., Ballman, K., Furth, A., Buckner, J.C. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology, 2009, 73, 1207-1213.
37. Patsalos, P.N., Froscher, W., Pisani, F, and van Rijn, C. The importance of drugs interactions in epilepsy therapy. Epilepsia, 2002, 43, 365-385.
38. Spina, E., Perucca, E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia, 2002, 43(Suppl 2), 37-44.
39. Patsalos, P.N., Perucca, E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol., 2003, 2, 347-356.
40. Vecht, C.J., Wagner, G.L., Wilms, E.B. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol., 2003, 2:404-409.
41. French, J.A. The role of drug-resistance proteins in medically refractory epilepsy. Epilepsy Curr., 2002, 2, 166-167.
42. Baltes, S., Gastens, A.M., Fedrowitz, M., Potschka, H., Kaever, V., Löscher, W. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology, 2007, 52, 333-346.
43. Löscher, W. How to explain multidrug resistance in epilepsy? Epilepsy Curr., 2005, 5, 107-112.
44. Taillibert, S., Laigle-Donadey, F., Sanson, M. Palliative care in patients with primary brain tumors. Curr. Opin. Oncol., 2004, 16, 587-592.
45. Rudà, R., Trevisan, E., Soffietti, R. Epilepsy and brain tumors. Curr. Opin. Oncol., 2010, 22, 611-620.
46. Maschio, M., Dinapoli, L., Zarabla, A., Pompili, A., Carapella, C.M., Pace, A., Giannarelli, D., Occhipinti, E., Jandolo, B. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J. Neurooncol., 2008, 86, 61-70.
47. Beghi, E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol., 2004, 3, 618-621.
48. French, J.A., Kanner, A.M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C.L., Theodore, W.H., Bazil, C., Stern, J., Schachter, S.C., Bergen, D., Hirtz, D., Montouris, G.D. Nespeca, M., Gidal, B., Marks, W.J. Jr, Turk, W.R., Fischer, J.H., Bourgeois, B., Wilner, A., Faught, R. E, Jr, Sachdeo, R.C., Beydoun, A., Glauser, T.A. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology, 2004, 62,1261-1273.
49. Zaccara, G., Messori, A., Cincotta, M., Burchini, G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol. Scand., 2006, 114, 157-168.
50. Cramer, J.A., French, J. Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components. Epilepsia, 2001, 42,119-129.
51. Maschio, M., Dinapoli, L., Gomellini, S., Ferraresi, V., Sperati, F., Vidiri, A., Muti, P., Jandolo, B. Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J. Neurooncol., 2010, 98, 109-116.
52. Maschio, M., Dinapoli, L., Saveriano, F., Pompili, A., Carapella, C.M., Vidiri, A., Jandolo, B. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report. Acta Neurol. Scand., 2009, 120, 210-212.
53. Maschio, M., Dinapoli, L., Zarabla, A., Jandolo, B. In reference to Bosma et al. The course of neurocognitive functioning in highgrade glioma patients. Neuro Oncol., 2008, 10, 106-107.
54. Maschio, M., Dinapoli, L., Sperati, F., Pace, A., Fabi, A., Vidiri, A, Muti, P. Levetiracetam monotherapy in patients with brain tumorrelated epilepsy: seizure control, safety, and quality of life. J. Neurooncology., 2011, 104, 205-214.
55. Maschio, M., Albani, F., Baruzzi, A., Zarabla, A., Dinapoli, L., Pace, A., Pompili, A., Carapella, C.M., Occhipinti, E., Jandolo, B. Levetiracetam therapy in patients with brain tumour and epilepsy. J. Neuro-oncol., 2006, 80, 97-100.
56. Novy, J., Stupp, R., Rossetti, A.O. Pregabalin in patients with primary brain tumors and seizures: a preliminary observation. Clin. Neurol. Neurosurg., 2009, 111, 171-173.
57. Maschio, M., Dinapoli, L., Mingoia, M., Sperati, F., Pace, A., Pompili, A., Carapella, C.M., Vidiri, A., Muti, P. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J. Neurol., 2011, 258, 2100-2104.
58. Kwan, P., Brodie, M.J. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia, 2004, 45, 1141-1149.
59. Aguiar, D., Pazo, R., Durán, I., Terrasa, J., Arrivi, A., Manzano, H., Martín, J., Rifá, J. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J. Neurooncol., 2004, 66, 345-350.
60. Bourg, V., Lebrun, C., Chichmanian, R.M., Thomas, P., Frenay, M. Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann. Oncol., 2001, 12, 217-219.
61. Curran, H.V., Java, R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur. J. Clin. Pharmacol., 1993, 44, 529-533.
62. Sabers A, Møller A, Dam M, Smed A, Arlien-Søborg P, Buchman J, Andersen EB, Boesen F, Dam AM, Lyon BB. Cognitive functions and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurol. Scand., 1995, 92, 19-27.
63. Wellington, K., Goa, K.L. Oxcarbazepine: an update of its efficacy in the management of epilepsy. CNS Drugs, 2001, 15, 137-163.
64. Salinsky, M.C., Storzbach, D., Spencer, D.C., Oken, B.S., Landry, T., Dodrill, C.B. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology, 2005, 64, 792-798.
65. Singh, B.K., White-Scott, S. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities. Seizure, 2002, 11, 47-50.
66. Meador, K.J., Loring, D.W., Hulihan, J.F., Kamin, M., Karim, R. CAPSS-027 Study Group. Differential cognitive and behavioral effects of topiramate and valproate. Neurology, 2003, 60, 1483-1488.
67. Kilpatrick, E.S., Forrest, G. Brodie, M.J. Concentration-effect and concentration-toxicity relations with lamotrigine: a prospective study. Epilepsia, 1996, 37, 534-538.
68. Sander, J.W., Hart, Y.M., Trimble, M.R., Shorvon, S.D. Vigabatrin and psychosis. J. Neurol. Neurosurg. Psychiatry, 1991, 54, 435-439.
69. Dichter, M.A., Brodie, M.J. New antiepileptic drugs. N. Engl. J. Med., 1996, 334,1583-1590.
70. Leppik, I.E. Three new drugs for epilepsy: levetiracetam, oxcarbazepine and zonisamide. J. Child Neurol., 2002, 17(Suppl 1), S53-57.
71. Sheth, R.D. Bone health in epilepsy. Lancet Neurol., 2004, 3, 516.
72. Maschio, M., Dinapoli, L., Vidiri, A., Pace, A., Fabi, A., Pompili, A., Carapella, M.C., Jandolo, B. The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. J. Exp. Clin. Cancer Res., 2009, 28, 60.
73. Striano, S., Striano, P., Boccella, P., Nocerino, C., Bilo, L. Tiagabine in glial tumors. Epilepsy Res., 2002, 49, 81-85.
74. Khan, R.B., Hunt, D.L., Thompson, S.J. Gabapentin to control seizures in children undergoing cancer treatment. J. Child Neurol., 2004, 19, 97-101.
75. Newton, H.B., Goldlust, S.A., Pearl, D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J. Neurooncol., 2006, 78, 99-102.
76. Maschio, M., Albani, F., Jandolo, B., Zarabla, A., Contin, M., Dinapoli, L., Fabi, A., Pace, A., Baruzzi, A. Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumorrelated epilepsy. J. Neurooncol., 2008, 90, 217-221.
77. Dinapoli, L., Maschio, M., Jandolo, B., Fabi, A., Pace, A., Sperati, F., Muti, P. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study. Neurol. Sci., 2009 May 5.
78. Maschio, M., Dinapoli, L., Vidiri, A., Muti, P. Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy. J. Neurol., 2010, 257, 1939-1940.
79. Arif, H., Buchsbaum, R., Weintraub, D., Pierro, J., Resor, S.R. Jr., Hirsch, L.J. Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav., 2009, 14, 202-209.
80. Bosma, I., Vos, M.J., Heimans, J.J., Taphoorn, M.J.B., Aaronson, N.K., Postma, T.J., Van der Ploeg H.M., Muller, M., Vandertop, W.P., Slotman, B.J., Klein, M. The course of neurocognitive functioning in high grade glioma patients. Neuro-Oncology, 2007, 9, 53-62.
81. Taphoorn, M.J., Klein, M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol., 2004, 3, 159-168.
82. Krychman, M.L., Amsterdam, A., Carter, J., Castiel, M., DeAngelis, L. Brain cancer and sexual health: a case report. Palliat Support Care, 2004, 2,315-318.
83. Smaldone, M., Sukkarieh, T., Reda, A., Khan, A. Epilepsy and erectile dysfunction: a review. Seizure, 2004, 13, 453-459.
84. Holtkamp, M., Weissinger, F., Meierkord, H. Erectile dysfunction with topiramate. Epilepsia, 2005,46,166-167.
85. Calabrò, R.S., Bramanti, P., Italiano, D., Ferlazzo, E. Epilepsy Behav., 2009, 14,560-561.
86. Maschio, M., Saveriano, F., Dinapoli, L., Jandolo, B. Reversible erectile dysfunction in a patient with brain tumor-related epilepsy in therapy with zonisamide in add-on. J. Sex Med., 2011, 8, 3515-3517.
87. Anderson, G.D. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology, 2004, 63, S3-S8.
88. Spina, E., Perucca, E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia, 2002,43(Suppl 2), 37-44.
89. Yap, K.Y., Chui, W.K., Chan, A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin. Ther., 2008, 30, 1385-1407.
90. Drappatz, J., Schiff, D., Kesari, S., Norden, A.D., Wen, P.Y. Medical management of brain tumor patients. Neurol. Clin., 2007, 25,1035-1071.
91. Relling, M.V., Pui, C.H., Sandlund, J.T., Rivera, G.K., Hancock, M. L, Boyett, J.M., Schuetz, EG., Evans, W.E. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet, 2000, 356, 285-290.
92. Gilbert, M.R., Supko, J.G., Batchelor, T., Lesser, G., Fisher, J.D., Piantadosi, S, Grossman S. Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma. Clin. Cancer Res., 2003, 9, 2940-2949.
93. Li, X.N., Shu, Q., Su, J.M., Perlaky, L., Blaney, S.M., Lau, C.C. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol. Cancer Ther., 2005, 4, 1912-1922.
94. Chavez-Blanco, A., Perez-Plasencia, C., Perez-Cardenas, E., Carrasco-Legleu, C., Rangel-Lopez, E., Segura-Pacheco, B., Taja-Chayeb, L., Trejo-Becerril, C., Gonzalez-Fierro, A., Candelaria, M., Cabrera, G., Duenas-Gonzalez, A. Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines. Cancer Cell Int., 2006, 31, 6, 2.
95. Weller, M., Gorlia, T., Cairncross, J.G., van den B. M.J., Mason, W., Belanger, K., Brandes, A.A., Bogdahn, U., Macdonald, D.R., Forsyth, P., Rossetti, A.O., Lacombe, D., Mirimanoff, R.O., Vecht, C.J., Stupp, R. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology, 2011, 77, 1156-1164.
96. Maschio, M., Dinapoli, L., Zarabla, A., Jandolo, B. Issues related to the pharmacological management of patients with brain tumours and epilepsy. Funct. Neurol., 2006, 21,15-19.
97. Sirven, J.I., Wingerchuk, D.M., Drazkowski, J.F., Lyons, M.K., Zimmerman, R.S. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin. Proc., 2004, 79,1489-1494.